eye treatment
Scope
Date
~
-
Korean startups
Asleep dreams big to help sleepless people worldwide find right treatment
Armed with artificial intelligence and big data technologies, Asleep hopes to find the best treatment for sleep-deprived people around the world wit...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
AbClon shows promising results in clinical tests of leukemia treatment
South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...
Apr 19, 2023 (Gmt+09:00)
-
Pre-IPOs
GS Group's petrochem equipment unit eyes up to $154 mn via pre-IPO
GS Entec Corp., a South Korean equipment maker for petrochemical and power plants, is set to raise 150 billion to 200 billion won ($115 million-$154...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...
Apr 13, 2023 (Gmt+09:00)
-
Korean startups
ASICLAND, TSMC’s sole Korean partner, eyes 2023 IPO
ASICLAND Co. is the only South Korean semiconductor design house for the world’s largest foundry TSMC Co., which manufactures chips for about ...
Apr 12, 2023 (Gmt+09:00)
-
Korean chipmakers
DRAM prices rebound on Samsung output cut; earlier recovery eyed
Memory chip prices are staging a rebound for the first time in more than a year following Samsung Electronics Co.'s near-term production cut, b...
Apr 12, 2023 (Gmt+09:00)
-
Korean stock market
Super-rich Koreans eye return to stocks despite weaker economy
The super-rich in South Korea are eyeing stocks for investments despite a slowdown in Asia’s fourth-largest economy this year, expecting the l...
Apr 10, 2023 (Gmt+09:00)
-
Earnings
LG Electronics eyes solid Q2 results after Q1 earnings surprise
LG Electronics Inc. is expected to report solid earnings for the second quarter after its first-quarter operating profit beat market expectations an...
Apr 09, 2023 (Gmt+09:00)
-
Private equity
MBK Partners eyes China’s local consumption: Letter to investors
Private equity giant MBK Partners focused on defending its portfolio last year, especially Chinese companies during the lockdown, while being active...
Apr 03, 2023 (Gmt+09:00)
-
Shareholder activism
S.Korean activist fund KCGI eyes foundry DB HiTek buyout
Korea Corporate Governance Improvement Fund (KCGI) is eyeing a controlling stake in DB HiTek Co. as the activist fund became the second-largest shar...
Mar 31, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's microneedle maker Raphas to enter US market
South Korea's microneedle maker Raphas Co. is expediting its entry into the American pharmaceutical market after entering the country's cosmetics se...
Mar 27, 2023 (Gmt+09:00)
-
Food & Beverage
Instant noodle maker Nongshim eyes 3rd plant in US
South Korean instant noodle giant Nongshim Co. is looking to build its third manufacturing plant in the US as the company is seeing sales of its pro...
Mar 24, 2023 (Gmt+09:00)
-
Bio & Pharma
US affiliate of Korea's cell therapy company NK Max eyes NYSE listing in 3Q
NKGen Biotech, the US affiliate of South Korea's natural killer (NK) cell therapy developer NK Max, on Friday said it signed a letter of intent (LOI) ...
Mar 24, 2023 (Gmt+09:00)
-
Bio & Pharma
PharmaResearch pays employees $7,706 bonus for having 3rd child
With South Korea setting new lows in birth rate every year, PharmaResearch on Wednesday said it will adopt an unprecedented system of childbirth and...
Mar 23, 2023 (Gmt+09:00)
-
Batteries
EcoPro taps mines in the Americas to secure cathode materials: EcoPro CEO
EcoPro Group, South Korea’s leading battery materials producer, is mulling investments in mines in the Americas to source cathode materials, a...
Mar 22, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion eyes Baxter's arm as it gears up for M&As
Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit ...
Mar 21, 2023 (Gmt+09:00)
-
Waste management
Toray Advanced Materials acquires S.Korea's water treatment company
Toray Advanced Materials Korea Inc. announced on Monday the acquisition of Hanmee Entec Co., Ltd., the industry's longest-running water treatment fa...
Mar 20, 2023 (Gmt+09:00)
-
Regulations
Korea to ease foreign ownership limit rules; MSCI upgrade eyed
South Korea plans to ease regulations that limit foreign ownership of big companies deemed crucial to its economy as the government aims to align it...
Mar 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)
-
Robotics
Samsung raises Rainbow Robotics stake, eyes management control
Samsung Electronics Co. is looking to own a controlling stake in Rainbow Robotics Co., a South Korean collaborative robot maker, as the tech giant h...
Mar 16, 2023 (Gmt+09:00)
-
Business & Politics
South Korea eyes $261 billion chip cluster; Samsung takes lead
South Korea said on Wednesday it will create the world’s largest semiconductor cluster near Seoul by attracting 340 trillion won ($261 billion...
Mar 15, 2023 (Gmt+09:00)
-
Aerospace & Defense
Boeing’s Korean supplier targets UAV market with guided weapons
Boeing Co.’s leading South Korean contractor aims to develop unmanned aerial vehicles with guided weapons, given the rapidly growing military ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile
South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...
Mar 14, 2023 (Gmt+09:00)
-
Travel & Leisure
H2O Hospitality rebrands itself as it eyes Middle East expansion
H2O Hospitality, a hospitality tech company that provides digital solutions for the hotel and tourism industry, said on Tuesday that it has rebrande...
Mar 10, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung, Arm partner Gaonchips eyes US as next offshore base
Gaonchips Co., a long-term Samsung Electronics Co’s chip design house partner that also works with British fabless chip company Arm Inc., will...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Upcoming IPOs
Korea’s sole foreign clinic operator CHA Healthcare to go public in 2025
CHA Healthcare Co. operating nearly 90 hospitals and infertility treatment centers across the world, is set to pave the way for South Koreans' inves...
Mar 08, 2023 (Gmt+09:00)
-
Electric vehicles
Hyundai eyes greater SUV market share with new Kona EV
Hyundai Motor Co. on Tuesday unveiled the all-new Kona Electric, its first fully revamped compact sport utility vehicle in five years, as the top So...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada
Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...
Mar 06, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand